Lenalidomide‐induced autoimmune enteropathy complicating treatment of multiple myeloma with concurrent systemic mastocytosis
oleh: Stephanie Lakritz, Peter A. Forsberg, Daniel W. Sherbenou, Tomer M. Mark
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2022-09-01 |
Deskripsi
Abstract Lenalidomide is an IMiD drug which has been associated with a variety of potential immune related complications. We describe the case of a patient with newly diagnosed multiple myeloma along with a history of systemic mastocytosis who developed evidence of an autoimmune enteropathy shortly after initiating lenalidomide based therapy.